About     Patient Stories     Committee

Documents

View the Terms of Reference here

View the BNMS Communications Strategy and Policy (including BNMS Social Media Policy) here

The Consortium will agree and deliver activities in accordance with a workplan, which will be developed with input from all Members.

The Workplan consists of 5 Workstreams as follows:
Action Plan Workstream 1: HARMONISATION AND DOSIMETRY
Action Plan Workstream 2: WORKFORCE
Action Plan Workstream 3: EQUITABLE ACCESS AND SERVICE MODELS
Action Plan Workstream 4: INFRASTRUCTURE AND RADIOPHARMACY
Action Plan Workstream 5: DATA COLLECTION
COMMUNICATIONS GROUP

View the RCR Report 'Proposals for the reshaping of cancer services in England: funding for innovative cancer treatments' here

View the Report of the NIHR Molecular Radiotherapy (MRT) National Research Access Network Meeting here

View the Review of Molecular Radiotherapy Services in the UK here

Targeted Radionuclide Therapy - Erasmus KCL White Paper - View here

Nearly double the patients and dramatic changes over 14 years of UK MRT: Internal Dosimetry Users Group survey results from 2007 to 2021 - Editorial in NMC view here

Guidance

Thyroid disease: assessment and management
EANM procedure guidelines for ¹³¹I-meta-iodobenzylguanidine (¹³¹I-mIBG) therapy
EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds
The SNM Practice Guideline for Therapy of Thyroid Disease with ¹³¹I 3.0*
NANETS/SNMMI Procedure Standard for Somatostatin Receptor–Based Peptide Receptor Radionuclide Therapy with ¹⁷⁷Lu-DOTATATE
ACR–ACNM–ASTRO–SNMMI PRACTICE PARAMETER FOR THE PERFORMANCE OF THERAPY WITH RADIUM-223
AUSTRALIAN PRODUCT INFORMATION SODIUM IODIDE [IODINE-131] THERAPY CAPSULE
Recommendations for the Provision of a Physics Service to Radiotherapy

Patient Preparation and Radiation Protection Guidance for Adult Patients Undergoing Radioiodine Treatment for Thyroid Cancer in the UK

ARSAC Guidance

How to submit practitioner licence applications to ARSAC: https://www.gov.uk/guidance/how-to-submit-practitioner-licence-applications-to-arsac

ARSAC Notes for Guidance: https://www.gov.uk/government/publications/arsac-notes-for-guidance
Specific sections for practitioners and therapy research:
Practitioner licences
3.14 – initial applications for therapy licences
3.19 – qualifications and experience of the practitioner
3.20-3.22 – Guidance for applicants who have not completed formal training schemes
3.31-3.36 – practical experience

Research approvals
4.12-4.14 – research involving therapy radiopharmaceuticals

Patient Questionnaire

Adrian Hardy has been asking patients for their thoughts on the treatment options, effects and impacts they have experienced during their illnesses. The questions set out, determined after consultation with BNMS members, are intended to encourage respondents to consider all aspects of their treatment and how it might be improved and what they would say to other patients about to consider similar treatment.

If you have patients who would be prepared to participate the questionnaire can be found HERE on the BNMS website

See below anonymised patient questionnaire results:
Patient A MRT patient discussion
Patient B MRT patient discussion
Patient C MRT patient discussion